DOTA Powder Cas No.60239-18-1
Source: Synthetic
Purity: ≥99%
CAS No: 60239-18-1
Molecular Formula: C₁₆H₂₈N₄O₈
Molecular Weight: 404.41 g/mol
Detection Method: HPLC
Active Ingredient: DOTA (1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid)
Appearance: White to off-white crystalline powder
Packaging: 1-25g/brown glass bottle or aluminum foil bag (customizable)
Storage: 2-8°C, dry and protected from light, sealed
Shelf Life: 24 months
Declaration of Use: This product is intended for industrial use or scientific research only.
DOTA Powder | CAS 60239-18-1 | High-Purity Macrocyclic Chelating Agent
Product Overview
DOTA (1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid) is the gold-standard macrocyclic chelating agent utilized in advanced medical imaging and radiopharmaceutical synthesis. Characterized by its unparalleled thermodynamic stability and kinetic inertness, DOTA forms rigid, stable complexes with lanthanide (e.g., Gd³⁺) and actinide ions, preventing the release of free toxic metals in vivo.
As a specialized API & peptide reagent supplier, Xi'an Tihealth Biotechnology Co., Ltd. provides pharmaceutical-grade DOTA powder. Our product is synthesized via optimized protocols to minimize trace metal contamination, ensuring its suitability for high-sensitivity PET/CT imaging and targeted radionuclide therapy (TRT).
Technical Data Sheet (TDS)
| Parameter | Specification (API Standard) |
| Chemical Name | 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid |
| CAS Number | 60239-18-1 |
| Molecular Formula | C16H28N4O8 |
| Assay (HPLC) | ≥ 98.0% (High-purity grades ≥ 99.5% available) |
| Structural Identity | Confirmed by 1H-NMR and MS spectrum |
| Appearance | White to off-white crystalline powder |
| Trace Metals (ICP-MS) | ≤ 10 ppm (Specific metals Fe, Cu, Zn strictly monitored) |
| Water Content (KF) | ≤ 10.0% (Anhydrous options available) |
| Solubility | Clear solution in Water (adjusted pH) or DMSO |
Core Applications & Research Utility
- Gadolinium-Based Contrast Agents (GBCAs): DOTA serves as the critical ligand for synthesizing Gadoterate Meglumine (Dotarem), providing the highest safety margin in MRI diagnostics by sequestering gadolinium ions.
- Radiopharmaceutical Labeling: Functions as a premier bifunctional chelator (BFC) for linking therapeutic or diagnostic isotopes (e.g., 177Lu, 68Ga, 90Y) to peptide-targeting vectors (e.g., DOTA-TATE, DOTA-NOC).
- Peptide Conjugation & R&D: Optimized for conjugation in solid-phase peptide synthesis (SPPS), supporting innovative pharmaceutical labs and academic research in oncology.
Quality Control & Storage
Analytical Support: Each batch is accompanied by a full Certificate of Analysis (COA), including HPLC purity profiles and NMR spectra to verify structural integrity.
Storage & Handling: DOTA powder is hygroscopic. Store in a cool, dry place under inert gas if possible. Recommended storage: 2-8°C. Keep container tightly sealed in a well-ventilated area.
Packaging: Standard sizes include 1g, 10g, 100g in glass vials; customized bulk packaging up to 25kg for industrial-scale manufacturing.
Products FAQ
Q1: What is the specific advantage of DOTA over EDTA or DTPA?
A: DOTA is a macrocyclic ligand, whereas EDTA and DTPA are linear. The "macrocyclic effect" provides significantly higher thermodynamic stability and slower dissociation kinetics, which is vital for preventing toxic metal release in medical applications.
Q2: Does Xi'an Tihealth support DMF or regulatory filings for DOTA?
A: Yes. We provide comprehensive technical data packages (TDS, MSDS, COA) and can support pharmaceutical manufacturers with the necessary documentation for DMF (Drug Master File) submissions and regulatory audits.
Hot Tags: dota powder cas no.60239-18-1, China dota powder cas no.60239-18-1 manufacturers, suppliers, factory, hialuronato de sodio hialuronato sodico sodium hyaluronate, , ,
You Might Also Like
Send Inquiry








